| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.051 | 0.3 |